Kawasaki disease occurs predominantly in children younger than 5 years of age. The disease is a febrile, multisystem illness of importance because of the risk of development of coronary artery abnormalities. Kawasaki disease is a generalized systemic vasculitis involving small to medium blood vessels throughout the body. Within several days of the onset of fever (persisting for at least 5 days), other characteristic features of the illness usually appear, including conjunctival infection without exudates; erythematous mouth and pharynx, strawberry tongue, and red, cracked lips; a polymorphous, generalized, erythematous rash; erythematous palms and soles; a unilateral cervical lymph node enlarged to at least 1.5 cm in diameter. Treatment with intravenous immunoglobulin and high-dose acetyl salicylic acid remains the primary management strategy. We report a case of acute Kawasaki disease in a 12-year-old girl who could not be given intravenous immunoglobulin in the first 10 days of the illness because of social security problems. Although she was given high-dose aspirin and steroids in the acute phase, she was successfully treated with intravenous immunoglobulin in the subacute phase

Keywords: Kawasaki diseasemucocutaneous lymph node syndrome, intravenous immunoglobulin